FXYD2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-49574
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Summary for FXYD2 Antibody
Immunogen
This antibody was developed against a recombinant protein corresponding to amino acids: SRRFRCGGNKKRRQINEDEP
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for FXYD2 Antibody
Immunohistochemistry-Paraffin: FXYD2 Antibody [NBP2-49574]
Immunohistochemistry-Paraffin: FXYD2 Antibody [NBP2-49574] - Staining of human kidney shows strong membranous positivity in cells in tubules.Applications for FXYD2 Antibody
Application
Recommended Usage
Immunohistochemistry
1:1000 - 1:2500
Immunohistochemistry-Paraffin
1:1000 - 1:2500
Application Notes
For IHC-Paraffin, HIER pH 6 retrieval is recommended.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: FXYD2
Long Name
Sodium/potassium-transporting ATPase subunit gamma
Alternate Names
ATP1C, ATP1G1
Gene Symbol
FXYD2
Additional FXYD2 Products
Product Documents for FXYD2 Antibody
Product Specific Notices for FXYD2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...